Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Ward, , Lydia,
DOB: 27-DEC-1968 (Age: 56)
Gender: female
Address:
6 Hunt radial
EH33 South Rosieside (United Kingdom)
ID: 8944-364030-8 (ECI)
Report
Date: 19-FEB-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Royal Hospital for Sick Children
EH9 2 Edinburgh (United Kingdom)
Specimen
Collected: 18-FEB-2022

Chemistry

Test 19-FEB-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4 - 6 %
Glucose [Mass/volume] in Blood 75.4 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.2 7 - 45 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 10.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 138.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.0 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.9 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 173.7 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 137.5 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 92.8 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 53.3 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The laboratory results are largely within normal limits, except for a mildly elevated HbA1c (6.2%), indicating impaired glucose metabolism or prediabetes. Renal function, electrolytes, and lipid profile are within reference ranges. Recommend clinical correlation for glycemic control and consideration of lifestyle modification or further evaluation for diabetes risk.